PAR paradigm biopharmaceuticals limited..

Ann: Consistent pain reduction and improvement in function data, page-6

  1. 879 Posts.
    lightbulb Created with Sketch. 363
    The only thing I would question in your Analysis Mozz is the word "modest". I think the income will be modest compared to say the US market OA but man once people can access it over here (knowing the likely outcome) ... I think Dr Bloom and others are going to need a "Bigger Boat" as demand in the scheme will be very high. Will be interesting to see if GP's will administer it which would increase access as Dr Bloom seems pretty busy.

    Once they determine the price for SAS treatements we will also have a better idea of the price going forward for our future projections.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
43.0¢
Change
-0.035(7.53%)
Mkt cap ! $170.8M
Open High Low Value Volume
47.0¢ 47.5¢ 42.0¢ $676.1K 1.519M

Buyers (Bids)

No. Vol. Price($)
2 16161 43.0¢
 

Sellers (Offers)

Price($) Vol. No.
44.5¢ 19584 1
View Market Depth
Last trade - 16.10pm 07/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.